Streetbeat News

Analyst Ratings

BBW

DA Davidson analyst Michael Baker has initiated coverage on Build-A-Bear Workshop (NYSE:BBW) with a Buy rating and a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:35 am

TLK

B of A Securities analyst Sukriti Bansal has downgraded Telkom Indonesia (NYSE:TLK) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:34 am

CIG

B of A Securities analyst Arthur Pereira has upgraded Cia Energetica DE Minas (NYSE:CIG) from Neutral to Buy.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:31 am

AZUL

Goldman Sachs analyst Bruno Amorim has upgraded Azul (NYSE:AZUL) from Neutral to Buy and raised the price target from $14.9 to $18.3.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:22 am

TIP

Economist Peter Schiff has warned that rising bond yields and energy prices could indicate worsening inflation. He suggested that if 10-year Treasury yields reach 7% and oil prices hit $150, it could be a sign of inflation. The yield on the 10-year Treasury note recently hit 4.372%, the highest since November 2017, due to investor expectations that the Fed might not reverse its rate hikes soon. Crude oil prices have also risen due to supply-side concerns. The iShares TIPS Bond ETF (TIP) ended Tuesday's session down 0.28% at $105.03.

Portfolio Pulse from Shanthi Rexaline

September 20, 2023 | 8:17 am

KR

Telsey Advisory Group analyst Joseph Feldman has reiterated an 'Outperform' rating on Kroger (NYSE:KR) and maintained a $55 price target.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:12 am

CWAN

Piper Sandler analyst Arvind Ramnani maintains a Neutral rating on Clearwater Analytics Hldg (NYSE:CWAN) and raises the price target from $17 to $20.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:11 am

BSX

Needham analyst Mike Matson has reiterated a 'Buy' rating on Boston Scientific (NYSE:BSX) and maintained a price target of $61.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:10 am

ARCT

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Arcturus Therapeutics (NASDAQ:ARCT) and maintained a $51 price target.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:10 am

DAVA

Needham analyst Mayank Tandon has maintained a 'Buy' rating on Endava (NYSE:DAVA) but lowered the price target from $68 to $65.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 8:09 am